Page last updated: 2024-12-06

difenoxin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Difenoxin is an opioid agonist with antidiarrheal properties. It is a prodrug of difenoxine, a synthetic opioid that binds to opioid receptors in the gastrointestinal tract, reducing peristalsis and slowing the passage of intestinal contents. Difenoxin is used to treat acute diarrhea in adults and children over 6 years old. It is typically administered orally and is absorbed rapidly from the gastrointestinal tract. Difenoxin has a relatively short duration of action, with effects lasting for several hours. It is metabolized in the liver and excreted in the urine. Difenoxin is available as a prescription medication in many countries, including the United States. The exact mechanism of action of difenoxin is not fully understood, but it is believed to work by reducing the motility of the gastrointestinal tract. This effect is mediated by the activation of opioid receptors in the gut. Difenoxin is also known to reduce the secretion of fluids into the gut, which may contribute to its antidiarrheal effects. Difenoxin has been studied for its potential use in the treatment of irritable bowel syndrome (IBS) and other gastrointestinal disorders. It has also been investigated for its potential use as an analgesic. Difenoxin is not currently available over-the-counter in the United States. Difenoxin is a Schedule V controlled substance in the United States. This means that it has a low potential for abuse and dependence. However, it is important to use difenoxin only as directed by a doctor, as it can cause side effects, including dizziness, drowsiness, constipation, and nausea.'

difenoxin: was EP to DIPHENOXYLATE (77-81); RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

difenoxin : A piperidinemonocarboxylic acid that is 4-phenylpiperidine-4-carboxylic acid in which the hydrogen attached to the nitrogen atom is substituted by a 3-cyano-3,3-diphenylpropyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID34328
CHEMBL ID1201321
CHEBI ID4534
SCHEMBL ID123801
MeSH IDM0262367

Synonyms (58)

Synonym
isonipecotic acid, 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-
1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid
mcn-jr 15,403-11
difenoxinum [inn-latin]
1-(3-cyan-3,3-diphenylpropyl)-4-phenyl-4-piperidincarbonsaeure
difenoxina [inn-spanish]
motofen
diphenoxin
difenossina [dcit]
mcn-jr 15403-11
4-piperidinecarboxylic acid, 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-
difenoxine
difenoxin [usan:inn:ban]
D03809
difenoxin (usan/inn)
C07871
difenoxin
28782-42-5
diphenoxilic acid
1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic acid
diphenoxylic acid
DB01501
lyspafen
difenoxinum
difenoxina
CHEBI:4534 ,
r-15403
acscn-9168
mcn-jr-15,403-11
r 15,403 [as hydrochloride]
ids-nd-007
CHEMBL1201321
unii-3zz5bj9f2q
3zz5bj9f2q ,
difenossina
difenoxin [mart.]
difenoxin [vandf]
difenoxin [mi]
difenoxin [who-dd]
r 15,403 free base
r-15403 free base
difenoxin [usan]
difenoxin [inn]
1-[3-cyano-3,3-di(phenyl)propyl]-4-phenylpiperidine-4-carboxylic acid
gtpl7592
SCHEMBL123801
difenoxylic acid
r-15403 [as hydrochloride] (salt/mix)
difenoxilic acid
motofen (salt/mix)
1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylic acid
difenoxin hydrochloride (salt/mix)
r-15403 (salt/mix)
mcn-jr-15403-11
DTXSID0022931
sr-01000944433
SR-01000944433-1
Q5275251

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" By 24 hr after dosing plasma levls had decreased to 14."( The evaluation and application of a radioimmunoassay for the measurement of diphenoxylic acid, the major metabolite of diphenoxylate hydrochloride (Lomotil), in human plasma.
Jackson, LS; Stafford, JE, 1987
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antidiarrhoeal drugAny drug found useful in the symptomatic treatment of diarrhoea.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
piperidinemonocarboxylic acidAny member of the class of piperidines in which one of the carbons of the piperidine ring is substituted by a carboxy group.
tertiary amineA compound formally derived from ammonia by replacing three hydrogen atoms by hydrocarbyl groups.
nitrileA compound having the structure RC#N; thus a C-substituted derivative of hydrocyanic acid, HC#N. In systematic nomenclature, the suffix nitrile denotes the triply bound #N atom, not the carbon atom attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (60.00)18.7374
1990's4 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.76 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index59.54 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]